Bcworldpharm Co (XKRX:200780) Other Stockholders Equity: ₩0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:200780 Bcworldpharm Co Ltd XKRX:200780
66 GF Score
Price ₩3,040.00
GF Value ₩5,477.85
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Bcworldpharm Co Other Stockholders Equity?

Bcworldpharm Co XKRX:200780 +1.00% 66 Other Stockholders Equity is ₩0 Mil as of Jun. 2026. GuruFocus rates XKRX:200780 with a GF Score™ of 66/100 and a GF Value™ of ₩5,477.85 (Possible Value Trap). The stock has 4 warning signs investors should review.

Bcworldpharm Co's Other Stockholders Equity for the quarter that ended in Jun. 2026 was ₩0 Mil.

Bcworldpharm Co's quarterly Other Stockholders Equity increased from Dec. 2025 (₩0 Mil) to Mar. 2026 (₩186 Mil) but then declined from Mar. 2026 (₩186 Mil) to Jun. 2026 (₩0 Mil).

Bcworldpharm Co's annual Other Stockholders Equity stayed the same from Dec. 2023 (₩0 Mil) to Dec. 2024 (₩0 Mil) but then declined from Dec. 2024 (₩0 Mil) to Dec. 2025 (₩0 Mil).

Bcworldpharm Co Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Bcworldpharm Co's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bcworldpharm Co Other Stockholders Equity Chart

Bcworldpharm Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 248.54 0.00 0.00 0.00 0.00

Bcworldpharm Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 185.88 0.00
XKRX:200780
66GF Score
Bcworldpharm Co Ltd XKRX:200780
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bcworldpharm Co Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of ₩0 Mil mean?
Bcworldpharm Co (XKRX:200780) has a Other Stockholders Equity of ₩0 Mil as of Jun. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Bcworldpharm Co and its competitors.
Is Bcworldpharm Co's Other Stockholders Equity too high?
Bcworldpharm Co's current Other Stockholders Equity is ₩0 Mil. Overall, Bcworldpharm Co has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bcworldpharm Co's Other Stockholders Equity compare to LLY and JNJ?
Bcworldpharm Co's Other Stockholders Equity of ₩0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Drug Manufacturers company?
A good Other Stockholders Equity depends on the Drug Manufacturers industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Bcworldpharm Co and its competitors. Bcworldpharm Co's current Other Stockholders Equity is ₩0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bcworldpharm Co stock overvalued right now?
Based on GuruFocus' analysis, Bcworldpharm Co (XKRX:200780) is currently considered Possible Value Trap. The stock's GF Value™ is ₩5,477.85, compared to a current price of ₩3,040.00 — trading 44.5% below its estimated fair value. The current Other Stockholders Equity is ₩0 Mil. Bcworldpharm Co's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Bcworldpharm Co (XKRX:200780), the current Other Stockholders Equity is ₩0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bcworldpharm Co (XKRX:200780) Overvalued in 2026?

Based on GuruFocus' analysis, Bcworldpharm Co stock appears to be undervalued. The current stock price of ₩3,040.00 is trading 44.5% below its estimated GF Value™ of ₩5,477.85. GuruFocus considers Bcworldpharm Co to be Possible Value Trap.

Key valuation signals for XKRX:200780:

  • Other Stockholders Equity: ₩0 Mil
  • GF Value™: ₩5,477.85 vs. price of ₩3,040.00 (44.5% below fair value)
  • GF Score™: 66/100 with 4 warning signs

No single metric tells the full story. See the XKRX:200780 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bcworldpharm Co Business Description

Address 872-23 Yeoju-nam-ro, Ganam-eup, Gyeonggi-do, Yeoju-si, KOR
Bcworldpharm Co Ltd is a pharmaceutical company. The company is engaged in research and develop new and improved drugs through R&D and technological innovation. The Company's products include Anti-TB, Anti-Diabetic, Analgesics, Narcotics Antidotes and Hemostatics.
66GF Score

Get the complete analysis for XKRX:200780

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩3,040.00
Price
₩5,477.85
GF Value